BRPI0417747A - uso de compostos orgánicos - Google Patents
uso de compostos orgánicosInfo
- Publication number
- BRPI0417747A BRPI0417747A BRPI0417747-9A BRPI0417747A BRPI0417747A BR PI0417747 A BRPI0417747 A BR PI0417747A BR PI0417747 A BRPI0417747 A BR PI0417747A BR PI0417747 A BRPI0417747 A BR PI0417747A
- Authority
- BR
- Brazil
- Prior art keywords
- organic compounds
- pharmaceutically acceptable
- pitavastatin
- statin
- medicament
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Child & Adolescent Psychology (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
"USO DE COMPOSTOS ORGáNICOS". A presente invenção refere-se ao uso de uma composição farmacêutica consistindo em estatina (especialmente fluvastatina ou pitavastatina) ou um sal farmaceuticamente aceitável da mesma e um veículo farmaceuticamente aceitável para a preparação de um medicamento para a prevenção ou tratamento da síndrome metabólica (ou síndrome X).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US52983103P | 2003-12-16 | 2003-12-16 | |
PCT/EP2004/014304 WO2005058310A2 (en) | 2003-12-16 | 2004-12-15 | Use of stating for the treatment of metabolic syndrome |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0417747A true BRPI0417747A (pt) | 2007-04-10 |
Family
ID=34700055
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0417747-9A BRPI0417747A (pt) | 2003-12-16 | 2004-12-15 | uso de compostos orgánicos |
Country Status (11)
Country | Link |
---|---|
US (1) | US20070275996A1 (pt) |
EP (1) | EP1699452A2 (pt) |
JP (1) | JP2007513991A (pt) |
KR (1) | KR20060124634A (pt) |
CN (1) | CN1889948A (pt) |
AU (1) | AU2004298351A1 (pt) |
BR (1) | BRPI0417747A (pt) |
CA (1) | CA2546793A1 (pt) |
MX (1) | MXPA06006831A (pt) |
RU (1) | RU2006125512A (pt) |
WO (1) | WO2005058310A2 (pt) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MX2008010879A (es) * | 2006-02-24 | 2008-10-27 | Teva Pharma | Composiciones farmaceuticas de sodio de fluvastatina. |
EP2000137B1 (en) * | 2006-03-29 | 2015-10-21 | Kowa Company, Ltd. | Triglyceride-lowering agent and hyperinsulinism-ameliorating agent |
EP1911441A3 (en) * | 2006-10-11 | 2008-08-06 | Lupin Limited | Controlled release color stable pharmaceutical dosage form of HMG-COA reductase inhibitors, free of alkalizing or buffering agents |
IS8612A (is) * | 2007-02-19 | 2008-08-20 | Actavis Group Ptc Ehf. | Stöðugar statínlyfjasamsetningar |
US8048880B2 (en) | 2007-05-03 | 2011-11-01 | Anthera Pharmaceuticals, Inc. | Treatment of cardiovascular disease and dyslipidemia using secretory phospholipase A2 (SPLA2) inhibitors and SPLA2 inhibitor combination therapies |
FR2987270A1 (fr) * | 2012-02-29 | 2013-08-30 | Agronomique Inst Nat Rech | Produit de combinaison pour le traitement du surpoids et/ou l'amelioration de la silhouette |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HUP0400475A3 (en) * | 2000-04-12 | 2006-02-28 | Novartis Ag | Pharmaceutical compositions containing combination of at least two compounds selected from an at1-receptor antagonist or an ace inhibitor or a hmg-co-a reductase inhibitor groups and use thereof |
AR039090A1 (es) * | 2002-03-22 | 2005-02-09 | Novartis Ag | Combinacion de compuestos organicos |
US20040053842A1 (en) * | 2002-07-02 | 2004-03-18 | Pfizer Inc. | Methods of treatment with CETP inhibitors and antihypertensive agents |
HUP0300990A2 (hu) * | 2003-04-15 | 2005-05-30 | SynoSens Kutató és Fejlesztő Kft. | Szinergista gyógyszer-kombináció a diabetesz megelőzésére vagy kezelésére |
WO2004096276A1 (ja) * | 2003-04-28 | 2004-11-11 | Sankyo Company, Limited | 糖取り込み能増強剤 |
-
2004
- 2004-12-15 AU AU2004298351A patent/AU2004298351A1/en not_active Abandoned
- 2004-12-15 EP EP04803921A patent/EP1699452A2/en not_active Withdrawn
- 2004-12-15 RU RU2006125512/15A patent/RU2006125512A/ru not_active Application Discontinuation
- 2004-12-15 BR BRPI0417747-9A patent/BRPI0417747A/pt not_active IP Right Cessation
- 2004-12-15 KR KR1020067011796A patent/KR20060124634A/ko not_active Application Discontinuation
- 2004-12-15 JP JP2006544330A patent/JP2007513991A/ja active Pending
- 2004-12-15 CA CA002546793A patent/CA2546793A1/en not_active Abandoned
- 2004-12-15 US US10/582,739 patent/US20070275996A1/en not_active Abandoned
- 2004-12-15 MX MXPA06006831A patent/MXPA06006831A/es not_active Application Discontinuation
- 2004-12-15 WO PCT/EP2004/014304 patent/WO2005058310A2/en not_active Application Discontinuation
- 2004-12-15 CN CNA2004800357954A patent/CN1889948A/zh active Pending
Also Published As
Publication number | Publication date |
---|---|
JP2007513991A (ja) | 2007-05-31 |
WO2005058310A3 (en) | 2005-08-25 |
US20070275996A1 (en) | 2007-11-29 |
MXPA06006831A (es) | 2006-08-23 |
EP1699452A2 (en) | 2006-09-13 |
CA2546793A1 (en) | 2005-06-30 |
CN1889948A (zh) | 2007-01-03 |
AU2004298351A1 (en) | 2005-06-30 |
RU2006125512A (ru) | 2008-01-27 |
KR20060124634A (ko) | 2006-12-05 |
WO2005058310A2 (en) | 2005-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0515896A (pt) | composto ou um sal ou éster farmaceuticamente aceitável do mesmo, método para o tratamento ou profilaxia de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus, e, composição farmacêutica para o tratamento de um hospedeiro infectado com uma infecção por flavivìrus, pestivìrus ou hepacivìrus | |
ATE339406T1 (de) | Chinazoline verbindungen als heilmittel | |
BR0107147A (pt) | Composições farmacêuticas de drogas anti-tuberculosas e processo para as suas preparações | |
RS114004A (en) | Modified 2' and 3'-nucleoside produgs for treating flaviridae infections | |
LU92496I2 (fr) | Combinaison de dapagliflozine ou d'un sel pharmaceutiquement acceptable de celle-ci et de merformineou d'un sel pharmaceutiquement acceptable de cell-ci, telle que protégée par le brevet de base EP1506211 B1 | |
BRPI0410049A (pt) | composto ou um sal ou estereoisÈmero farmaceuticamente aceitável do mesmo, uso de um composto, composição farmacêutica, e, kit farmacêutico | |
ITRM990338A0 (it) | Composizione dietetica o farmaceutica utile per la prevenzione o il trattamento dell'iperossaluria. | |
BRPI0507497A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, formulação farmacêutica, uso de um composto, e, métodos para prevenir e/ou tratar distúrbios mediados por receptor de mglur5 e para inibir a ativação de receptores de mglur5 | |
BR0215240A (pt) | Derivados de calcona e seu uso no tratamento de doenças | |
BR0315580A (pt) | Derivados de metileno uréia | |
BRPI0507966A (pt) | uso de meloxicam para o tratamento de doenças respiratórias em porcos | |
GEP20053675B (en) | Pyridazinone Aldose Reductase Inhibitors | |
DE50311898D1 (de) | Fredericamycin-derivate als arzneimittel zur tumorbehandlung | |
BR0314488A (pt) | Composto, composição farmacêutica e métodos de tratamento | |
BR0210028A (pt) | Agentes antibacterianos | |
ATE236147T1 (de) | Derivate von flavonen, xanthonen und kumarinen | |
BR0314182A (pt) | Formulações compreendendo um composto de indolinona | |
TR199900336T2 (xx) | EAA antagonistleri olarak tetrahidrokinolin t�revleri. | |
BRPI0508079A (pt) | composto ou uma forma cristalina ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, métodos de tratar ou prevenir uma infecção viral com hepatite c em um mamìfero e de inibir replicação de um vìrus da hepatite c | |
TR200002969T2 (tr) | Farmasötik bileşim. | |
BRPI0405657A (pt) | Método para o tratamento de insuficiência cardìaca grave e medicamento para o mesmo | |
BR0307588A (pt) | Composto, inibidor de gsk-3, composição farmacêutica, e, agente terapêutico ou preventivo para uma doença | |
BR0309757A (pt) | 6-alquilideno-penemas bicìclicos como inibidores de beta-lactamases | |
BRPI0514892A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
BRPI0417747A (pt) | uso de compostos orgánicos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A E 7A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |